During the past decade, University Fur Neurochirurgie, SALK, Christian Doppler Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Fur Neurochirurgie, SALK, Christian Doppler Hospital" are "Aneurysmal Subarachnoid Hemorrhage" (2 trials). Many other conditions were trialed in "University Fur Neurochirurgie, SALK, Christian Doppler Hospital" in a lesser frequency.

Most popular intervention types in "University Fur Neurochirurgie, SALK, Christian Doppler Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Clazosentan" (1 trials), "Clazosentan 15 mg/h" (1 trials) and "Clazosentan 5 m/h" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Fur Neurochirurgie, SALK, Christian Doppler Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University Fur Neurochirurgie, SALK, Christian Doppler Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University Fur Neurochirurgie, SALK, Christian Doppler Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Fur Neurochirurgie, SALK, Christian Doppler Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".